Key result
Higher plasma diacylglycerol levels are linked to faster carotid intima-media thickness progression in type 2 diabetes.
Why the study?
Are plasma diacylglycerol levels associated with carotid intima-media thickness progression in patients with type 2 diabetes?
Observational (n=254)
Are plasma diacylglycerol levels associated with carotid intima-media thickness progression in patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
Plasma diacylglycerol levels are associated with carotid intima-media thickness progression in patients with type 2 diabetes, suggesting their potential utility as a biomarker for atherosclerosis risk.
Abnormalities in plasma lipoproteins observed in patients with diabetes promote atherosclerosis. However, the association between various lipid species and classes and atherosclerosis remains unclear. Here, we aimed to identify the plasma lipid characteristics associated with atherosclerosis progression in patients with diabetes. We performed semi-targeted lipidomic analysis of fasting plasma samples using supercritical fluid chromatography coupled with mass spectrometry in two independent patient groups with type 2 diabetes (n = 223 and 31) and evaluated cross-sectional associations between plasma lipids and carotid intima-media thickness (CIMT). Ten plasma lipid species, including eight diacylglycerols (DGs), and total DG levels were significantly associated with CIMT in both groups. Patients of the former group were partly observed for 5 years, and we investigated associations between DGs and CIMT progression in these patients (n = 101). As a result, 22 DGs among the 26 identified DGs and total DG (β = 0.398, p < 0.001) were significantly associated with the annual change in CIMT. Furthermore, plasma DG levels improved the predictive ability for CIMT progression, with an adjusted R-squared increase of 0.105 [95% confidence interval: 0.010, 0.232] in the models. Plasma DGs are associated with CIMT progression in patients with type 2 diabetes. Measurement of total plasma DG levels may be beneficial in assessing the risk of atherosclerosis progression.
No takes yet. Share an insight, caveat, or question.
Taya et al. (2025) conducted an observational in Type 2 diabetes (n=254). Plasma diacylglycerols (DGs) was evaluated on Annual change in carotid intima-media thickness (CIMT) (β = 0.398, p=<0.001). Total plasma diacylglycerol levels were associated with the annual change in carotid intima-media thickness over 5 years in patients with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: